Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BAUER H., SCHMID O. Zur medikamentösen Behandlung der Myasthenie. Dtsch Z Nervenheilkd. 1953;169(6):427–437. [PubMed] [Google Scholar]
- CASIER H., VERBEKE R. Parasympathomimetic symptoms, sensitivity to acetylcholine and decurarization, in relation to inhibition of cholinesterases. Arch Int Pharmacodyn Ther. 1950 Aug 1;83(3):452–463. [PubMed] [Google Scholar]
- TETHER J. E. Treatment of myasthenia gravis with mestinon bromide. J Am Med Assoc. 1956 Jan 21;160(3):156–158. doi: 10.1001/jama.1956.02960380004002. [DOI] [PubMed] [Google Scholar]